%0 Journal Article
%T The right choice of antihypertensives protects primary human hepatocytes from ethanol- and recombinant human TGF-¦Â1-induced cellular damage
%A Ehnert S
%A Lukoschek T
%A Bachmann A
%A Martinez Sanchez JJ
%A Damm G
%A Nussler NC
%A Pscherer S
%A St ckle U
%A Dooley S
%A Mueller S
%A Nussler AK
%J Hepatic Medicine: Evidence and Research
%D 2013
%I 
%R http://dx.doi.org/10.2147/HMER.S38754
%X ight choice of antihypertensives protects primary human hepatocytes from ethanol- and recombinant human TGF-¦Â1-induced cellular damage Original Research (316) Total Article Views Authors: Ehnert S, Lukoschek T, Bachmann A, Martinez Sanchez JJ, Damm G, Nussler NC, Pscherer S, St ckle U, Dooley S, Mueller S, Nussler AK Published Date March 2013 Volume 2013:5 Pages 31 - 41 DOI: http://dx.doi.org/10.2147/HMER.S38754 Received: 03 October 2012 Accepted: 18 December 2012 Published: 22 March 2013 Sabrina Ehnert,1 Teresa Lukoschek,2 Anastasia Bachmann,2 Juan J Mart¨ªnez S¨¢nchez,1 Georg Damm,3 Natascha C Nussler,4 Stefan Pscherer,5 Ulrich St ckle,1 Steven Dooley,2 Sebastian Mueller,6 Andreas K Nussler1 1Eberhard Karls Universit t T¨¹bingen, BG Trauma Center, T¨¹bingen, Germany; 2Mol Hepatology - Alcohol Associated Diseases, Department of Medicine II, Medical Faculty, Mannheim, Germany; 3Department of General, Visceral, and Transplantation Surgery, Charit¨¦ University Medicine, Berlin, Germany; 4Clinic for General, Visceral, Endocrine Surgery and Coloproctology, Clinic Neuperlach, St dtisches Klinikum M¨¹nchen GmbH, Munich, Germany; 5Department of Diabetology, Klinikum Traunstein, Kliniken S¨¹dostbayern AG, Traunstein, Germany; 6Department of Medicine, Salem Medical Center, Ruprecht-Karls-Universit t, Heidelberg, Germany Background: Patients with alcoholic liver disease (ALD) often suffer from high blood pressure and rely on antihypertensive treatment. Certain antihypertensives may influence progression of chronic liver disease. Therefore, the aim of this study is to investigate the impact of the commonly used antihypertensives amlodipine, captopril, furosemide, metoprolol, propranolol, and spironolactone on alcohol-induced damage toward human hepatocytes (hHeps). Methods: hHeps were isolated by collagenase perfusion. Reactive oxygen species (ROS) were measured by fluorescence-based assays. Cellular damage was determined by lactate-dehydrogenase (LDH)-leakage. Expression analysis was performed by reverse-transcription polymerase chain reaction and Western blot. Transforming growth factor (TGF)-¦Â signaling was investigated by a Smad3/4-responsive luciferase-reporter assay. Results: Ethanol and TGF-¦Â1 rapidly increased ROS in hHeps, causing a release of 40%¨C60% of total LDH after 72 hours. All antihypertensives dose dependently reduced ethanol-mediated oxidative stress and cellular damage. Similar results were observed for TGF-¦Â1-dependent damage, except for furosemide, which had no effect. As a common mechanism, all antihypertensives increased heme-oxygenase-1 (HO-1) expression, and inhibition of HO-1 activity reversed the protective effect of the drugs. Interestingly, Smad3/4 signaling was reduced by all compounds except furosemide, which even enhanced this profibrotic signaling. This effect was mediated by expressional changes of Smad3 and/or Smad4. Conclusions: Our results suggest that antihypertensives may both positively and negatively influence chronic liver
%K primary human hepatocytes
%K alcoholic liver disease
%K ethanol
%K TGF-¦Â1
%K antihypertensives
%U https://www.dovepress.com/the-right-choice-of-antihypertensives-protects-primary-human-hepatocyt-peer-reviewed-article-HMER